Druggable	Report_C1	Report_C2	Tumor_VAF	Normal_VAF	DP_T	DP_N	SF_TVAF	SF_TDP	CHROM	Start	End	REF	ALT	FILTER	Gene	Transcript	Exon/Intron_Number	cHGVS	pHGVS	Type_Annotation	CLNSIG	CLNCONF	CLNDN	COSMIC	Related_Results
1	NRAS(0.1%)	exon4,c.437C>T,p.A146V	0.0008828	0.0008849	7713|7	1647|1	0.00128	19460|25	1	115252203	115252203	G	A	clustered_events,strand_bias,weak_evidence	NRAS	NM_002524.5	4	c.437C>T	p.Ala146Val	missense_variant				COSV65746912	
1	NRAS(28.3%)	exon3,c.182A>G,p.Q61R	0.283	0.001379	2983|1153	1140|1	0.26358	7580|2713	1	115256529	115256529	T	C	clustered_events	NRAS	NM_002524.5	3	c.182A>G	p.Gln61Arg	missense_variant	Pathogenic		Hepatocellular_carcinoma|Acute_myeloid_leukemia|Melanoma|Adrenal_cortex_carcinoma|B-cell_chronic_lymphocytic_leukemia|Large_congenital_melanocytic_nevus|Transitional_cell_carcinoma_of_the_bladder|Multiple_myeloma|Epidermal_nevus|Linear_nevus_sebaceous_syndrome|Renal_cell_carcinoma,_papillary,_1|Malignant_melanoma_of_skin|Lung_adenocarcinoma|Non-small_cell_lung_carcinoma|Neoplasm_of_brain|Gastric_adenocarcinoma|Nasopharyngeal_neoplasm|Neoplasm_of_the_large_intestine|Ovarian_serous_cystadenocarcinoma|Thyroid_cancer,_nonmedullary,_2|Neurocutaneous_melanocytosis|Glioblastoma|Malignant_neoplasm_of_body_of_uterus|not_provided		
	FMN2(1.8%)	exon5,c.2757_2822del,p.I920_G941del	0.018	0.021	375|7	61|0	0.01205	82|1	1	240370857	240370923	TCCCGGAGCGGGCATACCTCCTCCGCCGCCTCTACCCGGAGCAGGCATACTCCCTCTGCCCCCTCTA	T	PASS	FMN2	NM_020066.5	5	c.2757_2822del	p.Ile920_Gly941del	disruptive_inframe_deletion					
-	MSH2(6.4%)	exon2,c.212-5_212-4del	0.064	0.036	225|26	33|1	0.03985	771|32	2	47635523	47635525	CTT	C	multiallelic,normal_artifact	MSH2	NM_000251.3	1	c.212-5_212-4del		splice_region_variant&intron_variant	Likely_benign		not_specified		
-	MSH2(24.0%)	exon2,c.212-4del	0.24	0.307	225|84	33|21	0.19854	771|191	2	47635523	47635525	CTT	CT	multiallelic,normal_artifact,distinguished	MSH2	NM_000251.3	1	c.212-4del		splice_region_variant&intron_variant	Benign/Likely_benign		Lynch_syndrome_1|Hereditary_cancer-predisposing_syndrome|not_specified|not_provided		
-	MSH2(2.2%)	exon2,c.212-4T>A	0.022	0.03	399|9	81|1	0.02697	1335|37	2	47635536	47635536	T	A	normal_artifact,background	MSH2	NM_000251.3	1	c.212-4T>A		splice_region_variant&intron_variant	Likely_benign		Hereditary_nonpolyposis_colorectal_neoplasms		
-	MSH6(6.0%)	exon5,c.3261del,p.F1088fs	0.06	0.071	2733|207	480|39	0.05485	6410|372	2	48030639	48030640	AC	A	normal_artifact,slippage,suspected_bg	MSH6	NM_000179.3	5	c.3261del	p.Phe1088fs	frameshift_variant	Pathogenic		Lynch-like_syndrome|Endometrial_carcinoma|Carcinoma_of_colon|Lynch_syndrome|Colorectal_cancer,_hereditary_nonpolyposis,_type_5|Hereditary_cancer-predisposing_syndrome|Mismatch_repair_cancer_syndrome_3|Hereditary_nonpolyposis_colorectal_neoplasms|not_provided		
-	MSH6(22.2%)	exon7,c.3557-4del	0.222	0.131	26|8	7|0	0.16667	55|11	2	48032740	48032741	AT	A	germline,slippage,weak_evidence,suspected_bg	MSH6	NM_000179.3	6	c.3557-4del		splice_region_variant&intron_variant	Benign/Likely_benign		Colorectal_cancer,_hereditary_nonpolyposis,_type_5|Hereditary_cancer-predisposing_syndrome|not_specified|not_provided		
	RANBP2(1.5%)	exon20,c.4459_4650del,p.A1487_S1550del	0.015	0.01	940|18	282|2	*	0|0	2	109381429	109381621	AAAGGAAGGACAGTGGGATTGCAGTGCATGTTTGGTACAAAATGAGGGGAGCTCTACAAAATGTGCTGCTTGTCAGAATCCGAGAAAACAGAGTCTACCTGCTACTTCTATTCCAACACCTGCCTCTTTTAAGTTTGGTACTTCAGAGACAAGTAAAACTCTAAAAAGTGGATTTGAAGACATGTTTGCTAAG	A	normal_artifact	RANBP2	NM_006267.5	20	c.4459_4650del	p.Ala1487_Ser1550del	conservative_inframe_deletion					
	LRP1B(2.1%)	exon21,c.3258A>G,p.K1086=	0.021	0.007689	492|9	169|0	0.01543	638|10	2	141680595	141680595	T	C	distinguished	LRP1B	NM_018557.3	21	c.3258A>G	p.Lys1086=	synonymous_variant					
1	IDH1(0.2%)	exon4,c.395G>T,p.R132L	0.001531	0.001751	2545|6	756|0	0.00668	5056|34	2	209113112	209113112	C	A	base_qual,clustered_events,weak_evidence	IDH1	NM_005896.4	4	c.395G>T	p.Arg132Leu	missense_variant	Pathogenic/Likely_pathogenic		Hepatocellular_carcinoma|Acute_myeloid_leukemia|Medulloblastoma|Transitional_cell_carcinoma_of_the_bladder|Multiple_myeloma|Breast_neoplasm|Brainstem_glioma|Malignant_melanoma_of_skin|Lung_adenocarcinoma|Neoplasm_of_brain|Neoplasm_of_the_large_intestine|Adenoid_cystic_carcinoma|Prostate_adenocarcinoma|Glioblastoma|Myelodysplastic_syndrome		
	UGT1A1(0.9%)	exon,c.-55_-54insAT	0.008865	0.009296	2901|30	592|5	0.00681	10499|72	2	234668879	234668881	CAT	CATAT	clustered_events,multiallelic,normal_artifact,suspected_bg,chemotherapy_site	UGT1A1	NM_000463.3		c.-55_-54insAT		upstream_gene_variant	Conflicting_interpretations_of_pathogenicity|_drug_response|_other	Pathogenic(7)|_Uncertain_significance(1)|_Benign(3)	Gilbert_syndrome|Lucey-Driscoll_syndrome|Crigler-Najjar_syndrome,_type_II|Crigler-Najjar_syndrome_type_1|Bilirubin,_serum_level_of,_quantitative_trait_locus_1|Irinotecan_response|not_specified|not_provided		
2	FANCD2(8.4%)	exon6,c.378-5del	0.084	0.1	609|67	213|24	0.07925	976|84	3	10076842	10076843	CT	C	multiallelic,normal_artifact,slippage,suspected_bg	FANCD2	NM_001018115.3	5	c.378-5del		splice_region_variant&intron_variant					
2	FANCD2(4.2%)	exon6,c.378-5dup	0.042	0.011	609|36	213|5	0.04688	976|48	3	10076842	10076843	CT	CTT	multiallelic,normal_artifact,slippage,suspected_bg	FANCD2	NM_001018115.3	5	c.378-5dup		splice_region_variant&intron_variant					
	TGFBR2(11.5%)	exon4,c.458del,p.K153fs	0.115	0.136	541|84	180|34	0.09369	1006|104	3	30691871	30691872	GA	G	normal_artifact,slippage,suspected_bg	TGFBR2	NM_001024847.2	4	c.458del	p.Lys153fs	frameshift_variant	Conflicting_interpretations_of_pathogenicity	Likely_pathogenic(1)|_Benign(3)|_Likely_benign(1)	Loeys-Dietz_syndrome|Familial_thoracic_aortic_aneurysm_and_aortic_dissection|not_specified|Cardiovascular_phenotype|not_provided		
	MLH1(1.3%)	exon4,c.317G>A,p.S106N	0.013	0.005511	800|10	269|0	0.01034	1149|12	3	37045902	37045902	G	A	PASS	MLH1	NM_000249.4	4	c.317G>A	p.Ser106Asn	missense_variant	Uncertain_significance		Hereditary_cancer-predisposing_syndrome|Hereditary_nonpolyposis_colorectal_neoplasms|not_provided		
	ANO10(5.2%)	exon2,c.132del,p.D45fs	0.052	0.044	1615|116	613|33	0.04730	3283|163	3	43647212	43647213	CT	C	multiallelic,normal_artifact,slippage,suspected_bg	ANO10	NM_018075.5	2	c.132del	p.Asp45fs	frameshift_variant	Pathogenic		not_provided		
	ANO10(2.7%)	exon2,c.132dup,p.D45fs	0.027	0.025	1615|70	613|17	0.03640	3283|124	3	43647212	43647213	CT	CTT	multiallelic,normal_artifact,slippage,background	ANO10	NM_018075.5	2	c.132dup	p.Asp45fs	frameshift_variant	Pathogenic/Likely_pathogenic		Abnormal_central_motor_function|Autosomal_recessive_spinocerebellar_ataxia_10|Autosomal_recessive_cerebellar_ataxia|not_provided		
	PIK3CB(2.9%)	exon14,c.1810del,p.R604fs	0.029	0.03	269|7	47|0	0.02671	328|9	3	138413709	138413710	CG	C	suspected_bg	PIK3CB	NM_006219.3	14	c.1810del	p.Arg604fs	frameshift_variant					
	ATR(7.4%)	exon10,c.2320del,p.I774fs	0.074	0.073	3630|361	1041|99	0.06658	8370|597	3	142274739	142274740	AT	A	multiallelic,normal_artifact,slippage,suspected_bg	ATR	NM_001184.4	10	c.2320del	p.Ile774fs	frameshift_variant	Pathogenic		Endometrial_neoplasm|not_provided		
	ATR(0.8%)	exon10,c.2320dup,p.I774fs	0.008159	0.022	3630|67	1041|44	0.03103	8370|268	3	142274739	142274740	AT	ATT	multiallelic,normal_artifact,slippage,suspected_bg	ATR	NM_001184.4	10	c.2320dup	p.Ile774fs	frameshift_variant	Pathogenic/Likely_pathogenic		not_provided		
	FGFR3(2.1%)	exon12,c.1549A>G,p.K517E	0.021	0.039	289|4	35|0	0.00857	463|4	4	1807300	1807300	A	G	orientation	FGFR3	NM_000142.5	12	c.1549A>G	p.Lys517Glu	missense_variant					
	SLIT2(15.1%)	exon30,c.3158G>A,p.C1053Y	0.151	0.167	27|4	7|0	0.12500	28|4	4	20591336	20591336	G	A	orientation	SLIT2	NM_004787.4	30	c.3158G>A	p.Cys1053Tyr	missense_variant					
	KDR(1.5%)	exon13,c.1962C>T,p.C654=	0.015	0.008035	521|8	153|0	0.01480	799|12	4	55970835	55970835	G	A	background	KDR	NM_002253.3	13	c.1962C>T	p.Cys654=	synonymous_variant				COSV99818699	
	MSH3(1.8%)	exon7,c.1148del,p.K383fs	0.018	0.014	3033|75	923|20	0.01865	5999|114	5	79970914	79970915	CA	C	multiallelic,normal_artifact,slippage,background	MSH3	NM_002439.5	7	c.1148del	p.Lys383fs	frameshift_variant	Pathogenic		Endometrial_carcinoma|Hereditary_cancer-predisposing_syndrome|Familial_adenomatous_polyposis_4|not_provided		
	MSH3(2.0%)	exon7,c.1148dup,p.N385fs	0.02	0.027	3033|88	923|29	0.02376	5999|146	5	79970914	79970915	CA	CAA	multiallelic,normal_artifact,slippage,suspected_bg	MSH3	NM_002439.5	7	c.1148dup	p.Asn385fs	frameshift_variant	Pathogenic		not_provided		
-	APC(16.5%)	exon5,c.423-4del	0.165	0.138	213|57	77|15	0.15739	530|99	5	112111309	112111310	TA	T	germline,multiallelic,normal_artifact,suspected_bg	APC	NM_000038.6	4	c.423-4del		splice_region_variant&intron_variant	Benign/Likely_benign		Colorectal_cancer|Hereditary_cancer-predisposing_syndrome|Familial_adenomatous_polyposis_1|not_specified|not_provided		
-	APC(6.0%)	exon5,c.423-4dup	0.06	0.035	213|23	77|5	0.10473	530|62	5	112111309	112111310	TA	TAA	germline,multiallelic,normal_artifact,suspected_bg	APC	NM_000038.6	4	c.423-4dup		splice_region_variant&intron_variant	Benign		Hereditary_cancer-predisposing_syndrome|Familial_adenomatous_polyposis_1|not_specified		
-	APC(45.7%)	exon16,c.4188del,p.F1396fs	0.457	0.002179	1032|840	654|0	0.43260	1810|1380	5	112175475	112175476	GT	G	PASS	APC	NM_000038.6	16	c.4188del	p.Phe1396fs	frameshift_variant					
	RAD50(5.6%)	exon13,c.2165del,p.K722fs	0.056	0.046	1757|128	410|24	0.05455	3293|190	5	131931451	131931452	TA	T	multiallelic,normal_artifact,slippage,suspected_bg	RAD50	NM_005732.4	13	c.2165del	p.Lys722fs	frameshift_variant	Pathogenic		Nijmegen_breakage_syndrome-like_disorder|Hereditary_cancer-predisposing_syndrome		
	RAD50(1.7%)	exon13,c.2165dup,p.E723fs	0.017	0.021	1757|55	410|11	0.02545	3293|86	5	131931451	131931452	TA	TAA	multiallelic,normal_artifact,slippage,suspected_bg	RAD50	NM_005732.4	13	c.2165dup	p.Glu723fs	frameshift_variant	Pathogenic		Nijmegen_breakage_syndrome-like_disorder|Hereditary_cancer-predisposing_syndrome|Breast_and/or_ovarian_cancer|not_provided		
	RBM27(2.3%)	exon15,c.2448dup,p.Q817fs	0.023	0.007272	1896|63	565|8	0.02593	3794|101	5	145647319	145647320	TA	TAA	multiallelic,slippage,suspected_bg	RBM27	NM_018989.2	15	c.2448dup	p.Gln817fs	frameshift_variant&splice_region_variant					
	FGFR4(2.3%)	exon10,c.1263G>A,p.E421=	0.023	0.025	288|5	62|0	0.01330	371|5	5	176520418	176520418	G	A	orientation	FGFR4	NM_213647.3	10	c.1263G>A	p.Glu421=	synonymous_variant					
2	FLT4(7.1%)	exon6,c.677-1G>T	0.071	0.137	58|4	8|0	0.05970	63|4	5	180056836	180056836	C	A	orientation	FLT4	NM_182925.5	5	c.677-1G>T		splice_acceptor_variant&intron_variant					
	HLA-DQA1(6.0%)	exon2,c.122_126delinsCTTAT,p.F41S	0.06	0.07	190|9	47|2	0.04167	230|10	6	32609126	32609130	TTTAC	CTTAT	clustered_events,normal_artifact	HLA-DQA1	NM_002122.5	2	c.122_126delinsCTTAT	p.Phe41Ser	missense_variant					
	CARD11(3.6%)	exon15,c.1864_1866del,p.S622del	0.036	0.048	205|6	29|0	0.02422	282|7	7	2963940	2963943	GGGA	G	slippage,suspected_bg	CARD11	NM_032415.7	15	c.1864_1866del	p.Ser622del	conservative_inframe_deletion					
1	EGFR(0.3%)	exon20,c.2369C>T,p.T790M	0.002652	0.006609	1651|4	216|0	0.00190	2629|5	7	55249071	55249071	C	T	clustered_events,orientation,weak_evidence	EGFR	NM_005228.5	20	c.2369C>T	p.Thr790Met	missense_variant	drug_response		Non-small_cell_lung_carcinoma|Lung_carcinoma|Lung_cancer|Hereditary_cancer-predisposing_syndrome|Nonsmall_cell_lung_cancer,_resistance_to_tyrosine_kinase_inhibitor_in|EGFR-related_lung_cancer|Tyrosine_kinase_inhibitor_response|erlotinib_response_-_Efficacy|gefitinib_response_-_Efficacy|not_provided		
1	EGFR(0.1%)	exon21,c.2573T>G,p.L858R	0.001095	0.004436	2703|5	354|3	0.00559	4805|27	7	55259515	55259515	T	G	base_qual,clustered_events,orientation,strand_bias,weak_evidence	EGFR	NM_005228.5	21	c.2573T>G	p.Leu858Arg	missense_variant	drug_response		Lung_adenocarcinoma|Non-small_cell_lung_carcinoma|Lung_carcinoma|Adenocarcinoma_of_lung,_response_to_tyrosine_kinase_inhibitor_in,_somatic|Nonsmall_cell_lung_cancer,_response_to_tyrosine_kinase_inhibitor_in,_somatic|Erlotinib_response|Gefitinib_response|Tyrosine_kinase_inhibitor_response|gefitinib_response_-_Efficacy		
	EGFR(0.8%)	exon28,c.3366_3368delinsTCT,p.P1123L	0.007681	0.012	906|5	109|1	0.00373	1334|5	7	55273043	55273045	CCC	TCT	strand_bias,low_allele_frac	EGFR	NM_005228.5	28	c.3366_3368delinsTCT	p.Pro1123Leu	missense_variant					
	MAGI2(3.1%)	exon22,c.3823G>A,p.D1275N	0.031	0.05	151|4	28|0	0.03529	164|6	7	77649177	77649177	C	T	orientation	MAGI2	NM_012301.4	22	c.3823G>A	p.Asp1275Asn	missense_variant					
1	MET(0.1%)	exon14,c.3028+1G>A	0.0009537	0.00144	13710|14	3871|4	0.00110	53638|59	7	116412044	116412044	G	A	clustered_events,normal_artifact,weak_evidence	MET	NM_000245.4	14	c.3028+1G>A		splice_donor_variant&intron_variant	not_provided		not_provided		
	SMO(3.5%)	exon10,c.1779T>C,p.T593=	0.035	0.083	125|4	16|0	0.02532	154|4	7	128850932	128850932	T	C	orientation	SMO	NM_005631.5	10	c.1779T>C	p.Thr593=	synonymous_variant					
-	KMT2C(1.9%)	exon38,c.8390dup,p.E2798fs	0.019	0.02	7995|214	1915|59	0.03716	21194|818	7	151874147	151874148	CT	CTT	multiallelic,normal_artifact,slippage,suspected_bg	KMT2C	NM_170606.3	38	c.8390dup	p.Glu2798fs	frameshift_variant	Pathogenic		not_provided		
	MLLT3(2.7%)	exon5,c.489_566del,p.S164_S189del	0.027	0.012	1396|31	299|2	0.02479	236|6	9	20414277	20414355	ACTGCTGCTGCTGCTGCTGCTACTGCTGCTGCTACTGCTGCTGCTGCTGCTGCTGCTGCTGCTGCTACTGCTGCTGCTG	A	clustered_events	MLLT3	NM_004529.4	5	c.489_566del	p.Ser164_Ser189del	disruptive_inframe_deletion					
	PAX5(2.5%)	exon10,c.1143A>C,p.P381=	0.025	0.032	297|9	41|1	0.03318	408|14	9	36840590	36840590	T	G	orientation,suspected_bg	PAX5	NM_016734.3	10	c.1143A>C	p.Pro381=	synonymous_variant					
	FANCC(1.3%)	exon3,c.214G>A,p.A72T	0.013	0.008372	512|7	164|0	0.01014	683|7	9	98009750	98009750	C	T	PASS	FANCC	NM_000136.3	3	c.214G>A	p.Ala72Thr	missense_variant	Uncertain_significance		Fanconi_anemia_complementation_group_C|Hereditary_cancer-predisposing_syndrome|Fanconi_anemia|not_specified		
	IFITM3(7.4%)	exon1,c.208C>A,p.P70T	0.074	0.091	113|10	13|0	0.11348	125|16	11	320606	320606	G	T	background	IFITM3	NM_021034.3	1	c.208C>A	p.Pro70Thr	missense_variant				COSV67706711	
	IFITM3(10.1%)	exon1,c.165C>T,p.P55=	0.101	0.091	122|15	13|0	0.14103	134|22	11	320649	320649	G	A	background	IFITM3	NM_021034.3	1	c.165C>T	p.Pro55=	synonymous_variant				COSV67706701	
	MEN1(3.5%)	exon2,c.250T>G,p.S84A	0.035	0.044	126|4	23|0	0.06148	229|15	11	64577332	64577332	A	C	suspected_bg	MEN1	NM_000244.3	2	c.250T>G	p.Ser84Ala	missense_variant					
-	ATM(38.8%)	exon6,c.497-4del	0.388	0.471	31|28	7|10	0.25652	171|59	11	108114661	108114662	AT	A	germline,multiallelic,normal_artifact,distinguished	ATM	NM_000051.4	5	c.497-4del		splice_region_variant&intron_variant	Benign/Likely_benign		Hereditary_cancer-predisposing_syndrome|Familial_cancer_of_breast|not_specified|not_provided		
-	ATM(10.2%)	exon6,c.497-4dup	0.102	0.086	31|6	7|1	0.06044	171|11	11	108114661	108114662	AT	ATT	germline,multiallelic,normal_artifact,background	ATM	NM_000051.4	5	c.497-4dup		splice_region_variant&intron_variant	Benign/Likely_benign		Ataxia-telangiectasia_syndrome|Hereditary_cancer-predisposing_syndrome|not_specified|not_provided		
-	ATM(25.7%)	exon10,c.1236-3del	0.257	0.064	11|9	7|0	0.10000	90|10	11	108121410	108121411	CT	C	germline,multiallelic,slippage,weak_evidence,suspected_bg	ATM	NM_000051.4	9	c.1236-3del		splice_region_variant&intron_variant	Benign/Likely_benign		Ataxia-telangiectasia_syndrome|Hereditary_cancer-predisposing_syndrome|not_specified|Breast_and/or_ovarian_cancer|not_provided		
-	ATM(32.6%)	exon10,c.1236-3dup	0.326	0.323	11|8	7|4	0.14286	90|15	11	108121410	108121411	CT	CTT	germline,multiallelic,slippage,weak_evidence,suspected_bg	ATM	NM_000051.4	9	c.1236-3dup		splice_acceptor_variant&intron_variant	Benign/Likely_benign		Hereditary_cancer-predisposing_syndrome|not_specified|Breast_and/or_ovarian_cancer|not_provided		
	SIK2(4.1%)	exon15,c.2496A>C,p.P832=	0.041	0.036	169|6	29|0	0.08874	267|26	11	111594568	111594568	A	C	orientation,background	SIK2	NM_015191.3	15	c.2496A>C	p.Pro832=	synonymous_variant					
	CEP164(48.1%)	exon5,c.347del,p.K116fs	0.481	0.153	12|13	4|0	0.26667	44|16	11	117222647	117222648	GA	G	germline,Germline	CEP164	NM_014956.5	5	c.347del	p.Lys116fs	frameshift_variant	Benign		Nephronophthisis_15|not_provided		
	CD3G(5.0%)	exon3,c.213del,p.K71fs	0.05	0.032	845|51	225|9	0.04944	1365|71	11	118220582	118220583	TA	T	multiallelic,normal_artifact,slippage,background	CD3G	NM_000073.3	3	c.213del	p.Lys71fs	frameshift_variant	Conflicting_interpretations_of_pathogenicity	Pathogenic(1)|_Likely_pathogenic(1)|_Uncertain_significance(1)	Severe_combined_immunodeficiency_disease|Combined_immunodeficiency_due_to_CD3gamma_deficiency		
	CD3G(1.7%)	exon3,c.213dup,p.W72fs	0.017	0.009148	845|21	225|4	0.03054	1365|43	11	118220582	118220583	TA	TAA	multiallelic,normal_artifact,slippage,suspected_bg	CD3G	NM_000073.3	3	c.213dup	p.Trp72fs	frameshift_variant	Pathogenic/Likely_pathogenic		Severe_combined_immunodeficiency_disease|Combined_immunodeficiency_due_to_CD3gamma_deficiency		
1	KRAS(0.2%)	exon3,c.175G>A,p.A59T	0.00213	0.002311	5269|11	1864|3	0.00200	14941|30	12	25380283	25380283	C	T	clustered_events,normal_artifact	KRAS	NM_033360.4	3	c.175G>A	p.Ala59Thr	missense_variant	Pathogenic/Likely_pathogenic		Neoplasm_of_the_large_intestine|Bladder_cancer,_transitional_cell,_somatic		
1	KRAS(0.1%)	exon3,c.175G>T,p.A59S	0.0009991	0.0007934	5269|6	1864|3	0.00380	14941|57	12	25380283	25380283	C	A	clustered_events,normal_artifact	KRAS	NM_033360.4	3	c.175G>T	p.Ala59Ser	missense_variant	Pathogenic/Likely_pathogenic		not_provided		
1	KRAS(0.1%)	exon2,c.35G>A,p.G12D	0.001007	0.0006693	6380|5	2112|0	0.00061	17912|11	12	25398284	25398284	C	T	clustered_events,weak_evidence	KRAS	NM_033360.4	2	c.35G>A	p.Gly12Asp	missense_variant	Pathogenic		Vascular_Tumors_Including_Pyogenic_Granuloma|Acute_myeloid_leukemia|Cerebral_arteriovenous_malformation|Neoplasm_of_stomach|Nevus_sebaceous|Epidermal_nevus|Linear_nevus_sebaceous_syndrome|Juvenile_myelomonocytic_leukemia|Non-small_cell_lung_carcinoma|Thyroid_tumor|Neoplasm_of_ovary|Neoplasm_of_the_large_intestine|Lung_carcinoma|Carcinoma_of_pancreas|Encephalocraniocutaneous_lipomatosis|Autoimmune_lymphoproliferative_syndrome_type_4|Capillary_malformation-arteriovenous_malformation_1|RASopathy|Primary_low_grade_serous_adenocarcinoma_of_ovary|not_provided		
-	KMT2D(0.5%)	exon11,c.2263del,p.R755fs	0.004767	0.003767	4445|62	713|2	0.00982	15636|155	12	49445202	49445203	CG	C	clustered_events,low_allele_frac	KMT2D	NM_003482.4	11	c.2263del	p.Arg755fs	frameshift_variant	Pathogenic/Likely_pathogenic		Kabuki_syndrome_1		
	ERBB3(1.8%)	exon28,c.3926G>A,p.R1309H	0.018	0.021	351|5	69|0	0.01348	439|6	12	56495736	56495736	G	A	PASS	ERBB3	NM_001982.4	28	c.3926G>A	p.Arg1309His	missense_variant				COSV57256533	
	MVK(8.3%)	exon5,c.493C>T,p.P165S	0.083	0.143	54|4	8|0	0.05970	63|4	12	110019321	110019321	C	T	PASS	MVK	NM_000431.4	5	c.493C>T	p.Pro165Ser	missense_variant					
-	BRCA2(1.8%)	exon10,c.1813del,p.I605fs	0.018	0.034	2767|76	544|18	0.02119	5405|117	13	32907420	32907421	GA	G	normal_artifact,slippage,suspected_bg	BRCA2	NM_000059.4	10	c.1813del	p.Ile605fs	frameshift_variant	Pathogenic		Hereditary_breast_ovarian_cancer_syndrome|Fanconi_anemia_complementation_group_D1|Breast-ovarian_cancer,_familial,_susceptibility_to,_2|Hereditary_cancer-predisposing_syndrome|Familial_cancer_of_breast|not_provided		
	BRCA2(18.9%)	exon21,c.8687G>A,p.R2896H	0.189	0.004034	2002|460	358|0	0.19203	3042|723	13	32950861	32950861	G	A	PASS	BRCA2	NM_000059.4	21	c.8687G>A	p.Arg2896His	missense_variant	Conflicting_interpretations_of_pathogenicity	Uncertain_significance(4)|_Benign(1)|_Likely_benign(5)	Hereditary_breast_ovarian_cancer_syndrome|Malignant_tumor_of_breast|Breast-ovarian_cancer,_familial,_susceptibility_to,_2|Hereditary_cancer-predisposing_syndrome|not_specified|not_provided		
-	BRCA2(1.4%)	exon23,c.9097dup,p.T3033fs	0.014	0.005249	2612|44	461|3	0.01783	4518|82	13	32954022	32954022	C	CA	slippage,suspected_bg	BRCA2	NM_000059.4	23	c.9097dup	p.Thr3033fs	frameshift_variant	Pathogenic		Breast_carcinoma|Neoplasm_of_ovary|Hereditary_breast_ovarian_cancer_syndrome|Malignant_tumor_of_breast|Breast-ovarian_cancer,_familial,_susceptibility_to,_1|Breast-ovarian_cancer,_familial,_susceptibility_to,_2|Hereditary_cancer-predisposing_syndrome|Familial_cancer_of_breast|Breast_and/or_ovarian_cancer|not_provided		
	NBEA(0.9%)	exon22,c.3362dup,p.N1121fs	0.008905	0.006276	3422|38	975|5	0.00995	6071|61	13	35733662	35733662	T	TA	normal_artifact,slippage,suspected_bg	NBEA	NM_015678.5	22	c.3362dup	p.Asn1121fs	frameshift_variant	Likely_pathogenic		Neurodevelopmental_disorder_with_or_without_early-onset_generalized_epilepsy		
-	RB1(3.1%)	exon7,c.608-4del	0.031	0.03	7371|285	2183|79	0.03091	25023|798	13	48934140	48934141	AT	A	multiallelic,normal_artifact,slippage,suspected_bg	RB1	NM_000321.3	6	c.608-4del		splice_region_variant&intron_variant	Benign/Likely_benign		Retinoblastoma|Hereditary_cancer-predisposing_syndrome|not_provided		
-	RB1(2.1%)	exon7,c.608-4dup	0.021	0.028	7371|218	2183|80	0.03776	25023|982	13	48934140	48934141	AT	ATT	multiallelic,normal_artifact,slippage,suspected_bg	RB1	NM_000321.3	6	c.608-4dup		splice_region_variant&intron_variant	Benign		Retinoblastoma|Hereditary_cancer-predisposing_syndrome		
-	RB1(0.2%)	exon7,c.608-3C>T	0.002235	0.002828	8550|26	2503|7	0.00422	29056|123	13	48934150	48934150	C	T	normal_artifact,low_allele_frac	RB1	NM_000321.3	6	c.608-3C>T		splice_region_variant&intron_variant					
	HSP90AA1(4.2%)	exon6,c.1202_1204del,p.K401del	0.042	0.047	143|6	17|0	0.03125	279|9	14	102551160	102551163	ATCT	A	slippage,distinguished	HSP90AA1	NM_001017963.3	6	c.1202_1204del	p.Lys401del	disruptive_inframe_deletion					
	BLM(2.2%)	exon7,c.1544del,p.N515fs	0.022	0.025	2761|80	774|21	0.02690	5210|144	15	91304138	91304139	GA	G	multiallelic,normal_artifact,suspected_bg	BLM	NM_000057.4	7	c.1544del	p.Asn515fs	frameshift_variant	Pathogenic		Bloom_syndrome		
	BLM(1.5%)	exon7,c.1544dup,p.N515fs	0.015	0.017	2761|74	774|18	0.02489	5210|133	15	91304138	91304139	GA	GAA	multiallelic,normal_artifact,suspected_bg	BLM	NM_000057.4	7	c.1544dup	p.Asn515fs	frameshift_variant	Pathogenic/Likely_pathogenic		Hereditary_breast_ovarian_cancer_syndrome|Bloom_syndrome|Hereditary_cancer-predisposing_syndrome		
	CHD2(4.2%)	exon29,c.3734del,p.K1245fs	0.042	0.069	658|30	184|13	0.03545	1061|39	15	93540315	93540316	GA	G	multiallelic,normal_artifact,slippage,suspected_bg	CHD2	NM_001271.4	29	c.3734del	p.Lys1245fs	frameshift_variant&splice_region_variant	Conflicting_interpretations_of_pathogenicity	Pathogenic(3)|_Likely_pathogenic(1)|_Uncertain_significance(1)	Developmental_and_epileptic_encephalopathy_94|History_of_neurodevelopmental_disorder|not_specified|not_provided		
	CHD2(2.6%)	exon29,c.3734dup	0.026	0.025	658|23	184|3	0.03895	1061|43	15	93540315	93540316	GA	GAA	multiallelic,normal_artifact,slippage,suspected_bg	CHD2	NM_001271.4	29	c.3734dup		splice_donor_variant&intron_variant	Conflicting_interpretations_of_pathogenicity	Pathogenic(1)|_Likely_benign(1)	Developmental_and_epileptic_encephalopathy_94		
	TVP23A(2.9%)	exon5,c.420del,p.F140fs	0.029	0.009032	1356|54	155|1	0.03117	2238|72	16	10867202	10867203	TA	T	multiallelic,slippage,background	TVP23A	NM_001079512.4	5	c.420del	p.Phe140fs	frameshift_variant					
	PRSS8(0.5%)	exon5,c.642G>A,p.P214=	0.005102	0.009483	2676|13	299|1	0.00474	5675|27	16	31143813	31143813	C	T	background,low_allele_frac	PRSS8	NM_002773.5	5	c.642G>A	p.Pro214=	synonymous_variant				COSV54898066	
	TP53(35.4%)	exon5,c.524G>A,p.R175H	0.354	0.004834	826|443	263|0	0.36184	1418|804	17	7578406	7578406	C	T	PASS	TP53	NM_000546.6	5	c.524G>A	p.Arg175His	missense_variant	Pathogenic		Li-Fraumeni_syndrome_1|Hepatocellular_carcinoma|Neoplasm|Breast_neoplasm|Neoplasm_of_ovary|Choroid_plexus_papilloma|Carcinoma_of_colon|Bone_osteosarcoma|Carcinoma_of_pancreas|Colorectal_cancer|Malignant_tumor_of_esophagus|Adrenocortical_carcinoma,_hereditary|Squamous_cell_carcinoma_of_the_head_and_neck|Basal_cell_carcinoma,_susceptibility_to,_7|Hereditary_cancer-predisposing_syndrome|Nasopharyngeal_carcinoma|Familial_cancer_of_breast|Li-Fraumeni_syndrome|Lip_and_oral_cavity_carcinoma|Glioma_susceptibility_1|not_provided		
	TMEM97(0.4%)	exon3,c.443C>T,p.A148V	0.003839	0.002042	4069|15	723|0	0.00317	8485|27	17	26653731	26653731	C	T	low_allele_frac	TMEM97	NM_014573.3	3	c.443C>T	p.Ala148Val	missense_variant					
1	ERBB2(20.0%)	exon17,c.2033G>A,p.R678Q	0.2	0.018	426|108	78|0	0.20025	643|161	17	37879658	37879658	G	A	PASS	ERBB2	NM_004448.4	17	c.2033G>A	p.Arg678Gln	missense_variant	Likely_pathogenic		Transitional_cell_carcinoma_of_the_bladder|Breast_neoplasm|Gastric_adenocarcinoma|Neoplasm_of_the_large_intestine|Prostate_adenocarcinoma|Malignant_neoplasm_of_body_of_uterus		
	KRTAP4-7(11.4%)	exon1,c.91C>G,p.Q31E	0.114	0.101	58|4	12|0	0.09483	105|11	17	39240549	39240549	C	G	background	KRTAP4-7	NM_033061.3	1	c.91C>G	p.Gln31Glu	missense_variant				COSV66950990	
	KRTAP4-7(10.2%)	exon1,c.102T>C,p.C34=	0.102	0.111	67|4	11|0	0.09302	117|12	17	39240560	39240560	T	C	background	KRTAP4-7	NM_033061.3	1	c.102T>C	p.Cys34=	synonymous_variant				COSV66951539	
-	RNF43(5.0%)	exon9,c.1976del,p.G659fs	0.05	0.119	270|15	29|3	0.06157	442|29	17	56435160	56435161	AC	A	normal_artifact,suspected_bg	RNF43	NM_017763.6	9	c.1976del	p.Gly659fs	frameshift_variant	Likely_pathogenic		Sessile_serrated_polyposis_cancer_syndrome		
	MAP2K2(2.1%)	exon8,c.943G>A,p.A315T	0.021	0.059	281|6	18|0	0.01493	462|7	19	4097318	4097318	C	T	PASS	MAP2K2	NM_030662.4	8	c.943G>A	p.Ala315Thr	missense_variant					
	CIC(1.7%)	exon19,c.4394G>A,p.R1465H	0.017	0.038	306|4	31|0	0.01327	446|6	19	42798822	42798822	G	A	background	CIC	NM_015125.5	19	c.4394G>A	p.Arg1465His	missense_variant				COSV99360490	
	POLR1G(2.5%)	exon3,c.1505G>A,p.R502Q	0.025	0.078	180|4	15|0	0.01887	208|4	19	45912731	45912731	G	A	orientation	POLR1G	NM_012099.3	3	c.1505G>A	p.Arg502Gln	missense_variant					
	NCOA6(2.6%)	exon7,c.828_830del,p.Q277del	0.026	0.008361	899|22	119|2	0.02045	2587|54	20	33345720	33345723	TTGC	T	clustered_events,slippage,background	NCOA6	NM_014071.5	7	c.828_830del	p.Gln277del	disruptive_inframe_deletion	Likely_benign		not_provided		
	U2AF1(1.3%)	exon3,c.196C>T,p.R66C	0.013	0.019	545|7	83|0	0.01201	658|8	21	44520566	44520566	G	A	suspected_bg	U2AF1	NM_006758.3	3	c.196C>T	p.Arg66Cys	missense_variant				COSV52351031	
	CRKL(0.8%)	exon3,c.854T>C,p.L285P	0.007503	0.005979	1206|12	244|0	0.01741	2032|36	22	21304075	21304075	T	C	low_allele_frac	CRKL	NM_005207.4	3	c.854T>C	p.Leu285Pro	missense_variant					
	AMER1(2.1%)	exon2,c.2635C>T,p.H879Y	0.021	0.053	328|5	21|0	0.01157	427|5	X	63410532	63410532	G	A	orientation	AMER1	NM_152424.4	2	c.2635C>T	p.His879Tyr	missense_variant					
	MED12(2.4%)	exon10,c.1479G>A,p.G493=	0.024	0.045	247|6	23|0	0.01942	303|6	X	70342718	70342718	G	A	PASS	MED12	NM_005120.3	10	c.1479G>A	p.Gly493=	synonymous_variant					
	ATRX(0.8%)	exon9,c.835G>A,p.A279T	0.007611	0.011	919|8	128|0	0.00620	1283|8	X	76939913	76939913	C	T	low_allele_frac	ATRX	NM_000489.6	9	c.835G>A	p.Ala279Thr	missense_variant					
